\
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Wednesday, May 27, 2015
Question of the Day May 27, 2015 Are state boards of pharmacy willing to shoulder the responsiblity and not blame the FDA if another incident similiar to NECC from office use (non registered outsourcing facility) compounding occurs if Senator Vitter's amendment passes? What, other than voluntary registeration for outsourcing facilities, will be any different than pre-NECC if the amendment passes? Will it be a huge relief of FDA time and resources and a shield from future blame if Senator Vitter's Amendment passes? Why or why not? Where is the highest risk of a possible NECC like outbreak to the public? Would Senator Vitter's amendment reduce, increase or have no impact on that risk?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment